3rd Quarter - Report
FIRST PRINCIPLES STRATEGIES, LLC for IMMIX BIOPHARMA, INC.
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advancement of Congressional rare disease drug approval policies
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH ROBERT MURRAY | Senator Ron Johnson; Rep. Mark Meadows; Republican Study Committee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.